Ira Weisberg
Corporate Officer/Principal at ENDONOVO THERAPEUTICS, INC.
Profile
Ira Weisberg is currently the Chief Executive Officer & President at Sofpulse, Inc. and the President-Medical Division at Endonovo Therapeutics, Inc. He previously worked as the President & Chief Executive Officer at AlphaVax, Inc., the Chief Executive Officer at Amherst Pharmaceuticals LLC, and as the Vice President-Commercial Operations at Neurotrope, Inc. and Synaptogenix, Inc. He completed his undergraduate degree at St. John's University.
Ira Weisberg active positions
| Companies | Position | Start |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 30/11/2022 |
Sofpulse, Inc.
 Sofpulse, Inc. Medical SpecialtiesHealth Technology Sofpulse, Inc. develops and commercializes medical devices. The CEO of the American company is Ira Weisberg. | Chief Executive Officer | - |
Former positions of Ira Weisberg
| Companies | Position | End |
|---|---|---|
Amherst Pharmaceuticals LLC
 Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amherst Pharmaceuticals LLC is a private company that manufactures pharmaceutical products. The company is based in Basking Ridge, NJ. | Chief Executive Officer | - |
| SYNAPTOGENIX, INC. | Corporate Officer/Principal | - |
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Chief Executive Officer | - |
| NEUROTROPE, INC. | Corporate Officer/Principal | - |
Training of Ira Weisberg
| St. John's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| SYNAPTOGENIX, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |
Amherst Pharmaceuticals LLC
Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amherst Pharmaceuticals LLC is a private company that manufactures pharmaceutical products. The company is based in Basking Ridge, NJ. | Health Technology |
Sofpulse, Inc.
Sofpulse, Inc. Medical SpecialtiesHealth Technology Sofpulse, Inc. develops and commercializes medical devices. The CEO of the American company is Ira Weisberg. | Health Technology |
- Stock Market
- Insiders
- Ira Weisberg
